{"id":"https://openalex.org/W7222948596","doi":"https://doi.org/10.6084/m9.figshare.34694787","title":"Click chemistry-assisted synthesis of benzimidazole-1,2,3-triazole hybrids as potential anticancer and antioxidant agents: Integrated in vitro, in silico docking, ADMET, molecular dynamics, and DFT studies","display_name":"Click chemistry-assisted synthesis of benzimidazole-1,2,3-triazole hybrids as potential anticancer and antioxidant agents: Integrated in vitro, in silico docking, ADMET, molecular dynamics, and DFT studies","publication_year":2026,"publication_date":"2026-10-19","ids":{"openalex":"https://openalex.org/W7222948596","doi":"https://doi.org/10.6084/m9.figshare.34694787"},"language":"en","primary_location":{"id":"doi:10.6084/m9.figshare.34694787","doi":"https://doi.org/10.6084/m9.figshare.34694787","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34694787","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.6084/m9.figshare.34694787","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007387037","display_name":"Dharmesh A. Patel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dharmesh A. Patel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014521359","display_name":"Ranjitsinh C. Dabhi","orcid":"https://orcid.org/0000-0002-9519-2978","observed_orcids":["https://orcid.org/0000-0002-9519-2978"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ranjitsinh C. Dabhi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5137864257","display_name":"Apurva S. Prajapati","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Apurva S. Prajapati","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047622403","display_name":"Siddharth S. Patel","orcid":"https://orcid.org/0000-0001-8527-3267","observed_orcids":["https://orcid.org/0000-0001-8527-3267"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Siddharth S. Patel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016511649","display_name":"Dushyant D. Kotadiya","orcid":"https://orcid.org/0000-0001-6202-6351","observed_orcids":["https://orcid.org/0000-0001-6202-6351"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dushyant D. Kotadiya","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159045753","display_name":"Ann Maria Joseph","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ann Maria Joseph","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022548123","display_name":"Devendrasinh Jhala","orcid":"https://orcid.org/0000-0002-1339-6492","observed_orcids":["https://orcid.org/0000-0002-1339-6492"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Devendrasinh Jhala","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117127251","display_name":"Jay B. Maheta","orcid":"https://orcid.org/0009-0003-9332-1056","observed_orcids":["https://orcid.org/0009-0003-9332-1056"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jay B. Maheta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040358746","display_name":"Yogesh O. Bhola","orcid":"https://orcid.org/0000-0002-8882-5714","observed_orcids":["https://orcid.org/0000-0002-8882-5714"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yogesh O. Bhola","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5146707516","display_name":"Hitesh D. Patel","orcid":"https://orcid.org/0000-0002-0664-8874","observed_orcids":["https://orcid.org/0000-0002-0664-8874"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hitesh D. Patel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.51419997215271,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.51419997215271,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.3546999990940094,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11440","display_name":"Click Chemistry and Applications","score":0.11209999769926071,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cdk2-inhibitors","display_name":"CDK2 inhibitors","score":0.8539999723434448},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.9319999814033508},{"id":"https://openalex.org/keywords/antioxidant-activity","display_name":"antioxidant activity","score":0.9729999899864197},{"id":"https://openalex.org/keywords/free-radical-scavenging-activity","display_name":"free radical scavenging","score":0.8330000042915344},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.8220000267028809},{"id":"https://openalex.org/keywords/protein-ligand-binding","display_name":"protein-ligand binding","score":0.8109999895095825},{"id":"https://openalex.org/keywords/atp-binding-site","display_name":"ATP binding site","score":0.7739999890327454},{"id":"https://openalex.org/keywords/homo-lumo-gap","display_name":"HOMO-LUMO gap","score":0.8510000109672546},{"id":"https://openalex.org/keywords/admet-prediction","display_name":"ADMET prediction","score":0.7200000286102295},{"id":"https://openalex.org/keywords/click-chemistry","display_name":"click chemistry","score":0.4729999899864197},{"id":"https://openalex.org/keywords/molecular-dynamics-simulation","display_name":"molecular dynamics simulation","score":0.4699999988079071},{"id":"https://openalex.org/keywords/mm-gbsa-binding-free-energy","display_name":"MM-GBSA binding free energy","score":0.7599999904632568}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8062000274658203},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.7305999994277954},{"id":"https://openalex.org/C2778004101","wikidata":"https://www.wikidata.org/wiki/Q133948","display_name":"Antioxidant","level":2,"score":0.6599000096321106},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.6546000242233276},{"id":"https://openalex.org/C2986274086","wikidata":"https://www.wikidata.org/wiki/Q199678","display_name":"Ascorbic acid","level":2,"score":0.6442999839782715},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5540000200271606},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.5504000186920166},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5074999928474426},{"id":"https://openalex.org/C59593255","wikidata":"https://www.wikidata.org/wiki/Q901663","display_name":"Molecular dynamics","level":2,"score":0.45010000467300415},{"id":"https://openalex.org/C112887158","wikidata":"https://www.wikidata.org/wiki/Q169324","display_name":"Hydrogen bond","level":3,"score":0.44510000944137573},{"id":"https://openalex.org/C178910836","wikidata":"https://www.wikidata.org/wiki/Q2196961","display_name":"Molecular model","level":2,"score":0.4341000020503998},{"id":"https://openalex.org/C164126121","wikidata":"https://www.wikidata.org/wiki/Q766383","display_name":"Quantitative structure\u2013activity relationship","level":2,"score":0.4327999949455261},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.41679999232292175},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.40619999170303345},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.3763999938964844},{"id":"https://openalex.org/C53105671","wikidata":"https://www.wikidata.org/wiki/Q14777816","display_name":"Rational design","level":2,"score":0.3666999936103821},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.3465999960899353},{"id":"https://openalex.org/C147597530","wikidata":"https://www.wikidata.org/wiki/Q369472","display_name":"Computational chemistry","level":1,"score":0.3336000144481659},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.3050000071525574},{"id":"https://openalex.org/C192071366","wikidata":"https://www.wikidata.org/wiki/Q2991682","display_name":"Drug design","level":2,"score":0.288100004196167},{"id":"https://openalex.org/C33618052","wikidata":"https://www.wikidata.org/wiki/Q6013136","display_name":"In vitro toxicology","level":3,"score":0.28630000352859497},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.2815999984741211},{"id":"https://openalex.org/C3018146709","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Anticancer drug","level":3,"score":0.2815000116825104},{"id":"https://openalex.org/C41847442","wikidata":"https://www.wikidata.org/wiki/Q916723","display_name":"Lipinski's rule of five","level":4,"score":0.2775000035762787},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.2644999921321869},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.26100000739097595},{"id":"https://openalex.org/C186399102","wikidata":"https://www.wikidata.org/wiki/Q903517","display_name":"Chemical stability","level":2,"score":0.2531000077724457}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.6084/m9.figshare.34694787","doi":"https://doi.org/10.6084/m9.figshare.34694787","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34694787","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.6084/m9.figshare.34694787.v1","doi":"https://doi.org/10.6084/m9.figshare.34694787.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34694787.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.6084/m9.figshare.34694787","doi":"https://doi.org/10.6084/m9.figshare.34694787","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34694787","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"score":0.5683000087738037,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W6939307545","https://openalex.org/W4416224465","https://openalex.org/W4360990154","https://openalex.org/W7147040366","https://openalex.org/W4410983671","https://openalex.org/W4417156864","https://openalex.org/W4412187840","https://openalex.org/W4413326260","https://openalex.org/W4395043347","https://openalex.org/W4410022686"],"abstract_inverted_index":{"This":[0],"study":[1],"details":[2],"the":[3,25,67,70,134],"rational":[4],"design":[5],"and":[6,34,40,51,142],"synthesis":[7],"of":[8,69],"benzimidazole\u20131,2,3-triazole":[9],"hybrids":[10],"(10a-10o)":[11],"as":[12,36,38,149],"potential":[13,148],"CDK2":[14],"inhibitors":[15],"for":[16],"anticancer":[17],"treatment.":[18],"Molecular":[19,60],"docking":[20],"showed":[21,103],"strong":[22],"binding":[23,53],"within":[24],"ATP-binding":[26],"site,":[27],"with":[28],"key":[29],"hydrogen":[30],"bonds":[31],"to":[32,48,57,121],"Leu83":[33],"Asp86,":[35],"well":[37],"hydrophobic":[39],"\u03c0\u2013\u03c0":[41],"interactions.":[42],"Docking":[43],"scores":[44],"ranged":[45],"from":[46],"\u22127.93":[47],"\u22123.09":[49],"kcal/mol,":[50],"MM/GBSA":[52],"energies":[54],"reached":[55],"up":[56],"\u221250.01":[58],"kcal/mol.":[59],"dynamics":[61],"simulations":[62],"over":[63],"100":[64],"ns":[65],"verified":[66],"stability":[68],"protein\u2013ligand":[71],"complexes.":[72],"In":[73],"vitro":[74],"tests":[75],"against":[76],"MCF-7":[77],"cells":[78],"revealed":[79],"that":[80,109,131],"compound":[81,110],"10e":[82,132],"(IC50":[83,92,98,112,124],"=":[84,93,99,113,125],"14.55":[85],"\u00b5M)":[86,101],"was":[87],"more":[88],"effective":[89],"than":[90],"doxorubicin":[91],"15.77":[94],"\u00b5M),":[95],"while":[96],"10c":[97,111],"20.47":[100],"also":[102],"significant":[104],"activity.":[105],"Antioxidant":[106],"assays":[107],"indicated":[108],"50.80":[114],"\u00b5g/mL)":[115],"had":[116],"radical":[117],"scavenging":[118],"activity":[119],"comparable":[120],"ascorbic":[122],"acid":[123],"45.20":[126],"\u00b5g/mL).":[127],"DFT":[128],"analysis":[129],"found":[130],"has":[133],"lowest":[135],"HOMO\u2013LUMO":[136],"gap,":[137],"implying":[138],"higher":[139],"reactivity.":[140],"PCA":[141],"ADMET":[143],"assessments":[144],"further":[145],"supported":[146],"its":[147],"a":[150],"promising":[151],"drug":[152],"candidate.":[153]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-20T00:00:00"}